全球科技型医药制造服务领军
Apeloa (apeloa.com) earns a Brand Analyzer score of 63 out of 100, placing it in the Developing tier among Healthcare brands, Manufacturing brands. Among 2305 Healthcare brands analyzed, Apeloa ranks in the 24th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 95/100, Digital Presence 82/100, Visual Identity 93/100, Messaging Clarity 61/100, Trust Foundation 70/100, AI Discoverability 41/100, Brand Authority 16/100.
Apeloa, operating under Zhejiang Apeloa Pharmaceutical (stock code: 000739), is a Chinese pharmaceutical manufacturer founded in 1989. Ranked among China's top 36 pharmaceutical industrial enterprises, it holds the second position in API (active pharmaceutical ingredient) exports and ranks among the top five small-molecule CDMO companies in China. The company's business spans APIs, CDMO services, finished pharmaceuticals, and medical aesthetics and cosmetic ingredients.
| Brand Name | Apeloa |
|---|---|
| Domain | apeloa.com |
| Industry | Healthcare, Manufacturing |
| Founded | 1989 |
| Main Competitors | WuXi AppTec, Asymchem, Porton Pharma, Zhejiang Huahai Pharmaceutical (41/100), Aurobindo Pharma, Lonza |
Moz Domain Authority 19/100 vs category average 29 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #3,121,351 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "普洛药业(股票代码:000739)创立于1989年,位列中国医药工业企业36强,“原料药出口”第2位,中国小分子CDMO企业5强,为“中国最具成长性上市公司”百强企业,浙江省生物医药领军型企业和浙江省“雄鹰企业”。主营业务涉及原料药、CDMO、药品、医美及化妆品原料,各项板块业务高质量发展呈现新亮色。" (Meta description too short (1 words). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Instagram, YouTube, GitHub; no detected presence on X (Twitter), Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Apeloa scores 24/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Apeloa has a weak AI-visibility profile at 24/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is trust (10/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #3,121,351 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 19/100 and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Apeloa offers products and services across four main business segments: (1) Active Pharmaceutical Ingredients (APIs), where it is China's second-largest exporter; (2) CDMO (Contract Development and Manufacturing Organization) services for small molecules, ranking in China's top five; (3) finished pharmaceutical drug products; and (4) medical aesthetics and cosmetic raw materials. The company positions these segments as high-quality, innovation-driven offerings for global pharmaceutical and cosmetic industry clients.
Sources: Apeloa official site
Apeloa's main competitors include WuXi AppTec, Asymchem, Porton Pharma, Zhejiang Huahai Pharmaceutical (41/100), Aurobindo Pharma. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Apeloa official site
Apeloa and Zhejiang Huahai Pharmaceutical are competitors in Healthcare. Brand Analyzer scores Apeloa at 63/100 and Zhejiang Huahai Pharmaceutical at 41/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Apeloa official site
Popular alternatives to Apeloa include WuXi AppTec, Asymchem, Porton Pharma, Zhejiang Huahai Pharmaceutical (41/100), Aurobindo Pharma. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Apeloa official site
Apeloa (apeloa.com) is the brand identity of Zhejiang Apeloa Pharmaceutical Co., Ltd. (stock code: 000739), a Chinese pharmaceutical manufacturer founded in 1989. It ranks among China's top 36 pharmaceutical industrial enterprises and is recognized as one of China's top five small-molecule CDMO companies. The company is also designated as a leading biopharmaceutical enterprise in Zhejiang Province and a Zhejiang 'Eagle Enterprise,' and has been listed among China's top 100 most growth-oriented publicly traded companies.
Sources: Apeloa official site
Apeloa has low AI-search visibility, scoring 24/100 on Brand Analyzer's AI visibility composite (visibility 20, trust 10, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Apeloa official site
Apeloa engages in the development, manufacture, and export of active pharmaceutical ingredients (APIs), contract development and manufacturing (CDMO) services, finished pharmaceutical products, and medical aesthetics and cosmetic ingredients. It serves global pharmaceutical clients and CDMO customers through innovation-driven and advanced manufacturing capabilities, aiming to achieve what it describes as intelligent manufacturing upgrades across its business segments.
Sources: Apeloa official site
Apeloa is known for being the second-largest exporter of active pharmaceutical ingredients (APIs) in China and one of the top five small-molecule CDMO companies in the country. It is also recognized as one of China's top 36 pharmaceutical industrial enterprises. The company has earned designations as a leading biopharmaceutical enterprise in Zhejiang Province and a Zhejiang 'Eagle Enterprise,' and has been ranked among China's top 100 most growth-oriented listed companies.
Sources: Apeloa official site
Apeloa scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Apeloa official site
Apeloa's products and services are used by global pharmaceutical companies seeking API supply or CDMO manufacturing partnerships, as well as clients in the medical aesthetics and cosmetics ingredients industry. Its target audience, as stated in its value proposition, includes global pharmaceutical enterprises, CDMO customers, and companies in the medical aesthetics and cosmetics sector who require reliable, large-scale manufacturing and development services.
Sources: Apeloa official site
Apeloa is a publicly listed company on the Chinese stock market (stock code: 000739), which subjects it to regulatory disclosure and oversight requirements. It ranks among China's top 36 pharmaceutical industrial enterprises and holds the second position in API exports in China. It has been recognized as a leading biopharmaceutical enterprise in Zhejiang Province. These industry rankings and public listing status suggest a degree of institutional credibility, though independent verification of operations is advised.
Sources: Apeloa official site
Apeloa can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Apeloa official site
Apeloa's prominence stems from its strong positioning in the Chinese pharmaceutical manufacturing sector. It holds the second-largest share of API exports from China and is among the top five small-molecule CDMO companies in the country. Its broad service portfolio - spanning APIs, CDMO, finished drugs, and medical aesthetics ingredients - appeals to a wide range of global pharmaceutical and cosmetics clients. Its recognition as a high-growth listed company further supports its market reputation.
Sources: Apeloa official site
Ranked closest to Apeloa: AMS AI (63/100), AccurKardia (63/100), Appenzeller Kontaklinsen (63/100), Arontier (63/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).